Literature DB >> 33601700

Covid-19 pandemic and lockdown impacts: A description in a longitudinal study of bipolar disorder.

Anastasia K Yocum1, Yuqi Zhai2, Melvin G McInnis1, Peisong Han3.   

Abstract

OBJECTIVES: To investigate the impact of the SAR-Cov-2 pandemic and lockdown on individuals with bipolar disorder in comparison to healthy controls.
METHODS: A longitudinal study of 560 participants including 147 healthy controls was conducted between April 30 and May 30, 2020 during a state-wide lockdown. Bi-weekly measures included the Coronavirus Impact Scale, the Pittsburg Sleep Quality Index, the Patient Health Questionnaire, 9-item, and the Generalized Anxiety Disorder scale, 7-item. Generalized estimating equations method was used to examine the longitudinal change of the measures within the lockdown and the change from pre-pandemic period to pandemic period.
RESULTS: All participants reported an impact of lockdown. Individuals with bipolar disorder reported greater impact from the stay-at-home orders with disruptions in routines, income/employment, social support and pandemic related stress. While these measures improved over time, healthy controls recovered quicker and with greater magnitude than persons with bipolar disorder. Comparing mood symptom severity measures in mid-March through May 2020 to the same time window in 2015-2019 (pre- verses post-pandemic), there were no significant differences among individuals with bipolar disorder, whereas healthy controls showed a significant, albeit transient, increase in mood symptoms.
CONCLUSION: Everyone was impacted by the SARs-CoV pandemic; however, those with bipolar disorder experienced more life impacting changes from the stay-at-home orders vs healthy controls. These disruptions improved over time but much more slowly than healthy controls. Pre- vs post-pandemic comparisons show a modest but significant increase in mood severity in the healthy controls which was not observed in those with bipolar disorder.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Covid-19; Lockdown; Mood; Pandemic; Sleep

Mesh:

Year:  2021        PMID: 33601700     DOI: 10.1016/j.jad.2021.01.028

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  15 in total

Review 1.  The Acute Impact of the Early Stages of COVID-19 Pandemic in People with Pre-Existing Psychiatric Disorders: A Systematic Review.

Authors:  Sandra Carvalho; Catarina G Coelho; Bruno Kluwe-Schiavon; Juliana Magalhães; Jorge Leite
Journal:  Int J Environ Res Public Health       Date:  2022-04-23       Impact factor: 4.614

2.  Greater Emotional Distress Due to Social Distancing and Greater Symptom Severity during the COVID-19 Pandemic in Individuals with Bipolar Disorder: A Multicenter Study in Austria, Germany, and Denmark.

Authors:  Elena M D Schönthaler; Nina Dalkner; Michaela Ratzenhofer; Eva Fleischmann; Frederike T Fellendorf; Susanne A Bengesser; Armin Birner; Alexander Maget; Melanie Lenger; Martina Platzer; Robert Queissner; Adelina Tmava-Berisha; Christina Berndt; Julia Martini; Michael Bauer; Jon Dyg Sperling; Maj Vinberg; Eva Z Reininghaus
Journal:  Int J Environ Res Public Health       Date:  2022-06-22       Impact factor: 4.614

3.  Social Factors Predict Distress Development in Adults With Pre-existing Mental Disorders During the Coronavirus Disease 2019 Pandemic.

Authors:  Annika C Konrad; Katharina Förster; Marcel Kurtz; Tanja Endrass; Emanuel Jauk; Philipp Kanske
Journal:  Front Psychol       Date:  2022-07-01

4.  Psychological impact of the COVID-19 pandemic on individuals with serious mental disorders: A systematic review of the literature.

Authors:  Eva Fleischmann; Nina Dalkner; Frederike T Fellendorf; Eva Z Reininghaus
Journal:  World J Psychiatry       Date:  2021-12-19

5.  Impact of Workplace on the Risk of Severe COVID-19.

Authors:  Tsuyoshi Nakamura; Hiroyuki Mori; Todd Saunders; Hiroaki Chishaki; Yoshiaki Nose
Journal:  Front Public Health       Date:  2022-01-05

6.  Effects of the COVID-19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms.

Authors:  Manja Koenders; Rahele Mesbah; Annet Spijker; Elvira Boere; Max de Leeuw; Bert van Hemert; Erik Giltay
Journal:  Brain Behav       Date:  2021-09-23       Impact factor: 2.708

7.  The Intersection Between Childhood Trauma, the COVID-19 Pandemic, and Trauma-related and Psychotic Symptoms in People With Psychotic Disorders.

Authors:  Lena M D Stone; Zachary B Millman; Dost Öngür; Ann K Shinn
Journal:  Schizophr Bull Open       Date:  2021-11-10

8.  A longitudinal study of post-traumatic stress, depressive, and anxiety symptoms trajectories in subjects with bipolar disorder during the COVID-19 pandemic.

Authors:  Claudia Carmassi; Annalisa Cordone; Carlo Antonio Bertelloni; Andrea Cappelli; Virginia Pedrinelli; Gaia Sampogna; Gabriele Massimetti; Valerio Dell'Oste; Liliana Dell'Osso
Journal:  Eur Psychiatry       Date:  2022-01-13       Impact factor: 5.361

9.  Mental health in individuals with severe mental disorders during the covid-19 pandemic: a longitudinal investigation.

Authors:  Alex Hofer; Timo Kachel; Barbara Plattner; Anna Chernova; Andreas Conca; Martin Fronthaler; Christian Haring; Bernhard Holzner; Markus Huber; Josef Marksteiner; Carl Miller; Silvia Pardeller; Verena Perwanger; Roger Pycha; Martin Schmidt; Barbara Sperner-Unterweger; Franziska Tutzer; Beatrice Frajo-Apor
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-08

10.  Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders.

Authors:  Claus Wolff-Menzler; Michael Belz; Claudia Bartels; Philipp Hessmann; Ulrike Schmidt; Jonathan Vogelgsang; Mirjana Ruhleder; Alexander Kratzenberg; Marit Treptow; Thorgund Reh-Bergen; Mona Abdel-Hamid; Luisa Heß; Miriam Meiser; Jörg Signerski-Krieger; Katrin Radenbach; Sarah Trost; Björn H Schott; Jens Wiltfang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-11-25       Impact factor: 5.760

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.